Hussman Strategic Advisors Inc. continued to hold its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,000 shares of the company’s stock at the end of the second quarter. Hussman Strategic Advisors Inc.’s holdings in Nu Skin Enterprises were worth $126,000 as of its most recent filing with the SEC.
A number of other large investors have also bought and sold shares of NUS. Teachers Advisors LLC raised its stake in shares of Nu Skin Enterprises by 38.0% in the fourth quarter. Teachers Advisors LLC now owns 234,315 shares of the company’s stock valued at $11,196,000 after buying an additional 64,539 shares during the period. Creative Planning raised its stake in Nu Skin Enterprises by 38.5% in the first quarter. Creative Planning now owns 1,800 shares of the company’s stock worth $100,000 after buying an additional 500 shares during the period. Highland Capital Management LLC bought a new stake in Nu Skin Enterprises during the first quarter worth $313,000. Capstone Asset Management Co. acquired a new position in shares of Nu Skin Enterprises during the first quarter worth about $271,000. Finally, Louisiana State Employees Retirement System acquired a new position in shares of Nu Skin Enterprises during the first quarter worth about $694,000. 84.53% of the stock is owned by institutional investors.
Shares of Nu Skin Enterprises, Inc. (NYSE:NUS) traded up 3.16% during mid-day trading on Friday, reaching $55.48. 995,807 shares of the company’s stock traded hands. The stock has a market capitalization of $2.94 billion, a PE ratio of 18.56 and a beta of 1.31. Nu Skin Enterprises, Inc. has a 12-month low of $46.35 and a 12-month high of $66.04. The company’s 50-day moving average price is $61.67 and its 200-day moving average price is $56.55.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $0.77 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.08. The business had revenue of $550.10 million during the quarter, compared to the consensus estimate of $548.09 million. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The company’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.79 earnings per share. Analysts anticipate that Nu Skin Enterprises, Inc. will post $3.23 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Friday, August 25th will be issued a $0.36 dividend. The ex-dividend date is Wednesday, August 23rd. This represents a $1.44 dividend on an annualized basis and a yield of 2.60%. Nu Skin Enterprises’s payout ratio is 48.81%.
A number of research analysts have weighed in on the company. TheStreet upgraded Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Wednesday, August 2nd. Bank of America Corporation upped their price objective on Nu Skin Enterprises from $53.00 to $57.00 and gave the company an “underperform” rating in a research report on Monday, July 10th. BidaskClub cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Finally, Pivotal Research reissued a “buy” rating and set a $65.00 price target on shares of Nu Skin Enterprises in a report on Thursday, May 4th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $62.88.
In related news, President Ryan S. Napierski sold 8,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $65.00, for a total value of $520,000.00. Following the completion of the sale, the president now directly owns 68,170 shares in the company, valued at $4,431,050. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, General Counsel D Matthew Dorny sold 7,500 shares of Nu Skin Enterprises stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $60.88, for a total transaction of $456,600.00. Following the transaction, the general counsel now directly owns 52,230 shares in the company, valued at $3,179,762.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 31,750 shares of company stock valued at $1,946,810. 5.20% of the stock is owned by insiders.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.